Verifying Employment for Employees of Allied Technology Group (ATG) for Remedial Action Project at Weldon Springs Plant, Formerly Mallinckrodt
July 13, 2017
EEOICPA Dose Reconstruction Meeting
August 28, 2017

Two Pantex Plant employees examine the final B53 bomb prior to its dismantling. | Photo Courtesy of NNSA.

EEOICPA Special Exposure Cohort Coverage: Amarillo, Texas

Effective Feb. 3, 2017, the following class of workers was added to the Special Exposure Cohort of the EEOICPA. All employees of the U.S. Department of Energy, its predecessor agencies, and contractors and subcontractors who worked at the Amarillo, TX plant.

The qualifying dates of employment for this class are Jan. 1, 1951, through Dec. 31, 1957. This latest SEC class is an addition to the previous two classes at Pantex covering January 1, 1958 through December 31, 1983 and January 1, 1984, through December 31, 1991, extending the total SEC time frame there to forty years, from 1951 through 1991.

A worker who is included in a designated Special Exposure Cohort class, and who was diagnosed with one of 22 EEOICPA covered cancers may qualify for a presumption of causation under the EEOICPA, making the claims process easier. Qualifying employees must have worked at least 250 days, either solely under the above-mentioned employment, or in combination with workdays within the parameters established for one or more classes of employees included in the SEC.

The 22 Specified Cancers:

1 – Bone Cancer
2 – Renal Cancer
3 – Leukemia provided the the onset of the disease was at least two years after initial exposure
4 – Lung Cancer (other than in situ lung cancer that is discovered during or after a post-mortem exam)
5 – Multiple Myeloma provided onset was at least 5 years after the initial exposure
6 – Lymphomas (other than Hodgkin’s disease) provided onset was at least 5 years after the initial exposure

Primary cancer of the following (provided onset was at least 5 years after the initial exposure):

7 – Bile Ducts
8 – Brain (malignancies only, not including intracranial endocrine glands and other parts of the central nervous system)
9 – Breast (male)
10 – Breast (female)
11 – Colon (including rectal cancer)
12 – Esophagus
13 – Gall Bladder
14 – Liver (except if cirrhosis or hepatitis B is indicated)
15 – Ovary
16 – Pancreas
17 – Pharynx (including the soft palate, back of the mouth, base of the tongue, and the tonsils)
18 – Salivary Glands
19 – Small Intestine
20 – Stomach
21 – Thyroid
22 – Urinary Bladder (including ureter and urethra)

Need Help With Your EEOICPA Claim?

For more information about the new Pantex plant SEC, or to schedule an appointment for claim-filing assistance, contact EEOICPA Attorney Hugh Stephens at 1-855-EEOICPA (336-4272) or fill out the form to the right, whether or not you have already filed a claim and even if your claim has been accepted or denied.

Leave a Reply

Your email address will not be published. Required fields are marked *